Abbott has received FDA approval for the FlexNav transcatheter aortic valve replacement system combined with the Portico implant. It is designed to treat people with symptomatic severe aortic stenosis. Portico is a self-expanding valve with intra-ring flaps that help ensure optimal blood flow when placed inside the patient's aortic valve.